US Stock MarketDetailed Quotes
CHRO Chromocell Therapeutics
- 0.891
- +0.162+22.22%
Close Oct 16 16:00 ET
- 0.950
- +0.059+6.62%
Post 20:02 ET
5.14MMarket Cap-529P/E (TTM)
0.960High0.721Low983.80KVolume0.744Open0.729Pre Close899.81KTurnover74.21%Turnover RatioLossP/E (Static)5.77MShares6.00052wk High-27.84P/B1.18MFloat Cap0.52052wk Low--Dividend TTM1.33MShs Float6.000Historical High--Div YieldTTM32.77%Amplitude0.520Historical Low0.914Avg Price1Lot Size
Chromocell Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,424.85%-2.95M | -1,048.93%-1.99M | 37.40%-981.03K | 46.48%-356.81K | 0.22%-257.24K | 33.56%-193.62K | 50.65%-173.37K | 1.62%-1.57M | -114.48%-666.62K | -257.79K |
| Net income from continuing operations | -85.83%-1.77M | -165.10%-2.56M | -200.20%-7.38M | -221.22%-4.04M | -155.41%-1.42M | -185.39%-953.35K | -211.34%-966.56K | -312.94%-2.46M | -498.87%-1.26M | ---556.66K |
| Other non cash items | --0 | 1,813.52%605.63K | 177.52%389.72K | 657.85%322.93K | -386.51%-108.34K | 283.60%143.47K | 40.01%31.65K | --140.43K | --42.61K | --37.81K |
| Change In working capital | -667.56%-1.64M | -166.98%-327.75K | 220.05%2.05M | 24.19%544.04K | 179.18%728.8K | 5,406.33%288.92K | 870.74%489.32K | 184.79%640.86K | 534.39%438.05K | --261.05K |
| -Change in prepaid assets | --62.83K | ---220.93K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in payables and accrued expense | -689.30%-1.7M | -121.83%-106.82K | 220.05%2.05M | 24.19%544.04K | 351.67%728.8K | 3,480.14%288.92K | 1,365.74%489.32K | 177.43%640.86K | 534.39%438.05K | --161.36K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,424.85%-2.95M | -1,048.93%-1.99M | 37.40%-981.03K | 46.48%-356.81K | 0.22%-257.24K | 33.56%-193.62K | 50.65%-173.37K | 1.62%-1.57M | -114.48%-666.62K | ---257.79K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 599.54%1.59M | 3,294.63%5.67M | -36.98%1.02M | -21.52%430.41K | -53.78%198.13K | -22.77%226.91K | -52.49%166.9K | 1.83%1.62M | 76.46%548.45K | 428.64K |
| Net issuance payments of debt | 599.54%1.59M | -228.67%-214.76K | 91.73%766.94K | 75.00%175K | --198.13K | --226.91K | -44.37%166.9K | --400K | --100K | --0 |
| Net common stock issuance | --0 | --5.88M | --255.41K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.28%1.22M | 44.28%448.45K | --428.64K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 599.54%1.59M | 3,294.63%5.67M | -36.98%1.02M | -21.52%430.41K | -53.78%198.13K | -22.77%226.91K | -52.49%166.9K | 1.83%1.62M | 76.46%548.45K | --428.64K |
| Net cash flow | ||||||||||
| Beginning cash position | 7,656.40%3.77M | 75.02%96.39K | --55.07K | -86.85%22.79K | 3,330.79%81.89K | --48.61K | --55.07K | --0 | --173.24K | --2.39K |
| Current changes in cash | -4,201.34%-1.37M | 56,917.79%3.67M | -24.98%41.32K | 162.29%73.61K | -134.60%-59.11K | --33.29K | ---6.47K | --55.07K | ---118.17K | --170.85K |
| End cash Position | 2,836.88%2.41M | 7,656.40%3.77M | 75.02%96.39K | 75.02%96.39K | -86.85%22.79K | 3,330.79%81.89K | --48.61K | --55.07K | --55.07K | --173.24K |
| Free cash flow | -1,424.85%-2.95M | -1,048.93%-1.99M | 37.40%-981.03K | 46.48%-356.81K | 0.22%-257.24K | 33.56%-193.62K | 50.65%-173.37K | 1.62%-1.57M | -114.48%-666.62K | ---257.79K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
